Literature DB >> 1919020

A rapid FPLC method for purification of the third component of human and guinea pig complement.

M Basta1, C H Hammer.   

Abstract

A method is described for the purification of human and guinea pig C3 from small amounts of serum. This procedure requires only two steps--polyethylene glycol (PEG) precipitation and fast protein liquid chromatography (FPLC) Mono Q HR 10/10 ion exchange chromatography. The protocol takes less than two hours to complete and yields 4-6 mg of purified C3. Similar results, in terms of antigenic and functional recovery, were obtained for both human and guinea pig components. About 67% of C3 antigen was recovered from eluted fractions with fully preserved specific activity. Isolated C3 was over 95% pure as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography; this level of purity was confirmed by the absence of any observable contamination as assessed by immunoelectrophoresis using high titer anti-whole human serum. This method allows rapid and reproducible purification of fully active human or guinea pig C3 on a daily basis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919020     DOI: 10.1016/0022-1759(91)90290-v

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Authors:  Katerina Oikonomopoulou; Robert A DeAngelis; Hui Chen; Eleftherios P Diamandis; Morley D Hollenberg; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

2.  Complement deficiency promotes cutaneous wound healing in mice.

Authors:  Stavros Rafail; Ioannis Kourtzelis; Periklis G Foukas; Maciej M Markiewski; Robert A DeAngelis; Mara Guariento; Daniel Ricklin; Elizabeth A Grice; John D Lambris
Journal:  J Immunol       Date:  2014-12-29       Impact factor: 5.422

3.  Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activity.

Authors:  Georgia Sfyroera; Daniel Ricklin; Edimara S Reis; Hui Chen; Emilia L Wu; Yiannis N Kaznessis; Kristina N Ekdahl; Bo Nilsson; John D Lambris
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

4.  Deposition of complement components on Streptococcus agalactiae in bovine milk in the absence of inflammation.

Authors:  P Rainard; B Poutrel
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein Efb.

Authors:  Maria Georgoutsou-Spyridonos; Daniel Ricklin; Haris Pratsinis; Eustathia Perivolioti; Ioannis Pirmettis; Brandon L Garcia; Brian V Geisbrecht; Periklis G Foukas; John D Lambris; Dimitrios C Mastellos; Georgia Sfyroera
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

6.  The complement system of the goat: haemolytic assays and isolation of major proteins.

Authors:  Isabel Moreno-Indias; Alister W Dodds; Anastasio Argüello; Noemi Castro; Robert B Sim
Journal:  BMC Vet Res       Date:  2012-06-26       Impact factor: 2.741

7.  Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients.

Authors:  Mariann Kremlitzka; Bernadett Mácsik-Valent; Anna Polgár; Emese Kiss; Gyula Poór; Anna Erdei
Journal:  J Immunol Res       Date:  2016-11-17       Impact factor: 4.818

8.  Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses.

Authors:  Bernadett Mácsik-Valent; Katinka Nagy; László Fazekas; Anna Erdei
Journal:  Front Immunol       Date:  2019-07-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.